NO960715L - Fremgangsmåter for sceening av anti-östrogen forbindelser - Google Patents

Fremgangsmåter for sceening av anti-östrogen forbindelser

Info

Publication number
NO960715L
NO960715L NO960715A NO960715A NO960715L NO 960715 L NO960715 L NO 960715L NO 960715 A NO960715 A NO 960715A NO 960715 A NO960715 A NO 960715A NO 960715 L NO960715 L NO 960715L
Authority
NO
Norway
Prior art keywords
compounds
methods
reporter gene
estrogen compounds
scanning anti
Prior art date
Application number
NO960715A
Other languages
English (en)
Other versions
NO960715D0 (no
Inventor
Peter Kushner
Paul Wegg
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Publication of NO960715D0 publication Critical patent/NO960715D0/no
Publication of NO960715L publication Critical patent/NO960715L/no

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/743Steroid hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/721Steroid/thyroid hormone superfamily, e.g. GR, EcR, androgen receptor, oestrogen receptor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/723Steroid/thyroid hormone superfamily, e.g. GR, EcR, androgen receptor, oestrogen receptor
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
NO960715A 1993-09-01 1996-02-22 Fremgangsmåter for sceening av anti-östrogen forbindelser NO960715L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11516193A 1993-09-01 1993-09-01
PCT/US1994/009898 WO1995006754A1 (en) 1993-09-01 1994-09-01 Methods for screening antiestrogen compounds

Publications (2)

Publication Number Publication Date
NO960715D0 NO960715D0 (no) 1996-02-22
NO960715L true NO960715L (no) 1996-02-22

Family

ID=22359653

Family Applications (1)

Application Number Title Priority Date Filing Date
NO960715A NO960715L (no) 1993-09-01 1996-02-22 Fremgangsmåter for sceening av anti-östrogen forbindelser

Country Status (9)

Country Link
EP (1) EP0724648B1 (no)
JP (1) JP3503945B2 (no)
KR (1) KR100355647B1 (no)
AT (1) ATE236247T1 (no)
AU (1) AU682398B2 (no)
CA (1) CA2169466A1 (no)
DE (1) DE69432422T2 (no)
NO (1) NO960715L (no)
WO (1) WO1995006754A1 (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5723291A (en) * 1993-09-01 1998-03-03 The Regents Of The University Of California Methods for screening compounds for estrogenic activity
US6156723A (en) 1993-09-01 2000-12-05 The Regents Of The University Of California Compositions comprising inhibitors of estrogen response
GB9424497D0 (en) * 1994-12-05 1995-01-25 Karobio Ab Reporter cell line
AU2287397A (en) * 1996-03-14 1997-10-01 Schering Aktiengesellschaft Method of detecting the effect of test substances using hen urokinase
US5965543A (en) * 1996-04-18 1999-10-12 Geron Corporation Senescence responsive transcriptional element
US5783435A (en) * 1996-08-06 1998-07-21 Lamparski; Henry G. Prostate cancer drug screenings
US6051417A (en) * 1996-08-06 2000-04-18 Calydon, Inc. Prostate cancer drug screening using hKLK2 enhancer
DE60030796T2 (de) 1999-04-14 2007-09-13 Sumitomo Chemical Co., Ltd. Zelle zur Bestimmung der Fähigkeit die Aktivität eines Liganden-abhängigen Transkriptionskontrollfaktors zu kontrollieren
AU2009301457B2 (en) * 2008-10-09 2015-08-13 Merck Patent Gmbh Estrogen and anti-estrogen marker genes

Also Published As

Publication number Publication date
NO960715D0 (no) 1996-02-22
JP3503945B2 (ja) 2004-03-08
EP0724648A1 (en) 1996-08-07
WO1995006754A1 (en) 1995-03-09
EP0724648B1 (en) 2003-04-02
DE69432422T2 (de) 2004-03-04
AU682398B2 (en) 1997-10-02
ATE236247T1 (de) 2003-04-15
AU7719094A (en) 1995-03-22
KR100355647B1 (ko) 2002-12-28
CA2169466A1 (en) 1995-03-09
DE69432422D1 (de) 2003-05-08
EP0724648A4 (en) 1996-10-09
JPH09502345A (ja) 1997-03-11

Similar Documents

Publication Publication Date Title
CA2215922A1 (en) Methods for screening compounds for estrogenic activity
ATE248170T1 (de) Kinase-inhibitoren mit hoher affinität zur ziel detektion und ihre verwendung
EP1616942A3 (en) Patched genes and their use
DE60141950D1 (de) Vernetzte, nicht von pilzen kommende lipase enthaltende zusammensetzung und methoden zu deren verwendung
AR003140A1 (es) Nuevos compuestos utiles para inhibir las interacciones de las tirosinaquinasas/proteinas adaptadoras, composiciones farmaceuticas que lascontienen y metodos de aplicacion de dichos compuestos para inhibir dichas interacciones.
ATE311363T1 (de) Sulfohydroxamsäure and sulfohydroxamate und ihre verwendung als mek-inhibitoren
GB2318580B (en) Microspheres with fluorescent spherical zones
EA199700087A1 (ru) Способ ингибирования катепсина к
ATE225772T1 (de) Thrombin-inhibitoren
DK0873340T3 (da) Heterocyklisk substituerede cyclopentanforbindelser
NO960715D0 (no) Fremgangsmåter for sceening av anti-östrogen forbindelser
ATE109510T1 (de) Pdgf-alpha-rezeptor.
DE69942063D1 (de) Antagonisten von 'hedgehog' und 'patched' zur inhibierung des wachstums und der differenzierung von zellen und geweben, als auch deren verwendungen
NO953270L (no) Fibrinogenreceptorantagonister
BR0311318A (pt) Inibidores de peptìdeo desformilase
KR950030812A (ko) 살충 혼합물
CA2170757A1 (en) Method of marking eukaryotic cells by the use of a cell surface receptor as a marker
DE69417248D1 (de) Delta 16 ungesättigtes c17 heterocyclische steroide zur verwendung als steroid c17-20 lyase inhibitoren
SE8802944D0 (sv) Materials for patch testing
BR9901058A (pt) N-cail e n-aroil aralquil amidas.
NO954328L (no) Nye substituerte 1-fenyl-pyridinyl-benzotriazoler
DE68910676D1 (de) Verwendung von Creosot als antispastischer Wirkstoff.
EA199900241A1 (ru) ЗАМЕЩЕННЫЕ 1,2,3,4-ТЕТРАГИДРО-2-ДИБЕНЗОФУРАНАМИНЫ И 2-АМИНОЦИКЛОГЕПТА [b] БЕНЗОФУРАНЫ
DE69526738T2 (de) Endothelin-rezeptor-antagonisten
WO1999038975A3 (en) Polynucleotide and polypeptide sequences associated with cns depressant sensitivity and methods of use thereof

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application